Optiver Holding
NMRA icon

Optiver Holding’s Neumora Therapeutics NMRA Stock Holding History

Optiver Holding’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$340 Buy
+200
New +$381 ﹤0.01% 2597
2026
Q1 		– Sell
-592
Closed -$1.06K – 2606
2025
Q4 		$1.06K Buy
+592
New +$1.3K ﹤0.01% 2210

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Optiver Holding's NMRA Position: Q2 2026 in Review

Optiver Holding opened a new position in Neumora Therapeutics (NMRA) in Q2 2026: 200 shares worth $340. The stake represents ﹤0.01% of the portfolio and ranks #2597 among its holdings. This is a return to the name: Optiver Holding previously reported a position in NMRA as recently as Q4 2025.

Optiver Holding first reported a position in NMRA in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.06K in Q4 2025. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • Optiver Holding held 200 shares of Neumora Therapeutics worth $340 as of Q2 2026.
  • Neumora Therapeutics was a new Optiver Holding position in Q2 2026.
  • Neumora Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2597 holding.
  • Optiver Holding first reported a position in Neumora Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Optiver Holding's Neumora Therapeutics position peaked at $1.06K in Q4 2025.
  • 113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.